Skip to main content
SAGE Open Medical Case Reports logoLink to SAGE Open Medical Case Reports
. 2024 Sep 30;12:2050313X241288341. doi: 10.1177/2050313X241288341

Is the presence of upper tract transitional cell carcinoma in a calyceal diverticulum a risk factor for early metastasis? A case report and review of the literature

Mahmoud Mustafa 1,2,, Hatem Hijaz 1,2, Amir Aghbar 1,2, Abdelkarim Barqawi 1,3, Ibraheem Alami 1,2, Nabil Khalil 1,2
PMCID: PMC11468008  PMID: 39399581

Abstract

Upper tract transitional cell carcinoma poses diagnostic challenges due to its prevalence and diverse clinical presentations. This case report describes the incidental discovery of high-grade transitional cell carcinoma during the management of a 48-year-old male with ischemic heart disease and an asymptomatic right renal stone. During flexible ureteroscopy for stone removal, papillary lesions were identified within a calyceal diverticulum and confirmed as high-grade transitional cell carcinoma. The unique anatomy of the calyceal diverticulum, characterized by its restricted wall thickness, may predispose the tumor to early metastasis. Additionally, there is a concern about potential iatrogenic dissemination of tumor cells to the bladder during the ureteroscopic procedure. This case highlights the diagnostic complexities associated with upper tract transitional cell carcinoma in rare anatomical locations and emphasizes the need for careful consideration of both procedural factors and anatomical features to manage the risk of metastasis and tumor dissemination effectively.

Keywords: Upper tract transitional cell carcinoma, calyceal diverticulum, tumor dissemination, metastasis, ureteroscopic procedure

Introduction

Upper tract urothelial carcinoma (UTUC) constitutes fewer than 5% of urothelial cancers. 1 The precise etiology of upper urinary tract transitional cell carcinoma (TCC) remains elusive, although several discernible risk factors have been established. These include exposure to a spectrum of chemicals, 2 susceptibility to infections, pharmaceutical influences, genetic predispositions, dietary patterns, 3 and tobacco consumption. 4 Males have a higher incidence of developing this condition compared to females. 5 Upper urinary tract stones, often associated with recurrent urinary tract infections, pose a notable risk for upper tract cancers such as squamous cell carcinoma, TCC, and adenocarcinoma, and this risk is attributed to chronic inflammation leading to urothelial proliferation and malignant transformation. 5 UTUC arising within a calyceal diverticulum is an exceedingly uncommon pathological occurrence, with documented cases in the medical literature being exceptionally rare.57 Herein, we present a case of UTUC that was uniquely discovered during flexible ureteroscopy for a symptomatic calyceal kidney stone.

Case presentation

A 48-year-old male patient with a history of ischemic heart disease and an asymptomatic right renal stone since childhood presented to our urology department with severe right flank pain accompanied by nausea. He reported experiencing mild episodes of right flank pain over the 2 months prior to his presentation but sought medical attention only after his last episode. He denied experiencing dysuria or hematuria.

A renal computed tomography (CT) scan without intravenous (IV) contrast revealed several findings: a horseshoe kidney, a 2-cm renal calculus on the right side, and a large renal cyst measuring 7 cm × 6 cm, with no significant hydronephrosis. Microscopic hematuria was detected in the lab results. Consequently, the patient underwent right retrograde ureteral stenting due to difficult access caused by a tight right ureteric orifice. After 1 month, he underwent laser lithotripsy of his right kidney stone using flexible ureteroscopy and replacement of the ureteral stent. During the procedure, while fragmenting the stone (Figure 1(a)), which was located in a calyceal diverticulum abutting the middle calyx and had a narrow opening that needed to be dilated to gain access, several papillary lesions were incidentally discovered (Figure 1(b)–(d)). Cytology was obtained and sent for histopathological analysis, revealing high-grade TCC, category VI according to Paris reporting system. 8

Figure 1.

Figure 1.

Images obtained during flexible ureteroscopy of the right kidney. (a) Right kidney stone, (b) papillary lesions protruding into the lumen of the diverticulum, (c) image showing the stone before fragmentation and the papillary lesions, (d) the stone after fragmentation with the surrounding papillary lesions.

Further staging was conducted through a CT-scan of the chest, abdomen, and pelvis with IV contrast, which revealed additional abnormalities including a relatively well-defined cystic structure with thick wall seen in the mid portion of right kidney measuring about 4.5 cm with multiple adjacent stones/calcifications. The right kidney presented urothelial thickening and surrounding fat stranding (Figure 2). Subsequently, the patient underwent a right radical nephroureterectomy with bladder cuff excision and insertion of a left ureteral stent. The procedure started with cystoscopy that showed small bladder lesions on the left lateral wall and doom, which were not resected or biopsied as these lesions were not typical of papillary growth and were considered as a reactionary lesion caused by the DJ stent. Histopathological examination confirmed a unifocal, invasive papillary urothelial carcinoma, high-grade, pT1, located in the lower pole of the right kidney, measuring 3.5 cm × 3.5 cm. The tumor showed no necrosis or invasion, and the ureteric and vascular margins were free of tumor (Figure 3).

Figure 2.

Figure 2.

CT scan with IV contrast, the venous phase is showed. (a) and (b) Coronal views. (c) and (d) axial views showing: horseshoe kidneys with duplex calyceal system, a relatively well-defined cystic structure with thick wall seen in the mid portion of right kidney measures about 4.5 cm with multiple adjacent stones/calcifications. The right kidney presents urothelial thickening and surrounding fat stranding. The DJ-stent seen in the right upper calyceal group.

Figure 3.

Figure 3.

(a) Gross picture of resected right kidney, right ureter, and bladder cuff. (b) histopathologic examination showed papillary urothelial carcinoma, high-grade, with invasion into the subepithelial tissue (pT1).

Postoperatively, the patient remained stable with no significant decline in hemoglobin levels or serum creatinine and was discharged 3 days later. One month after his major operation, he underwent cystoscopy revealing multiple small papillary lesions throughout the urinary bladder, almost over all walls, with a noticeable location around the right ureteric orifice. Radical transurethral resection of the bladder tumor was done and histopathology showed non-invasive papillary urothelial carcinoma, WHO low grade, with no lamina propria, muscularis propria, or lymphovascular invasion seen. The patient received a 6-week induction course of intravesical Bacillus Calmette–Guérin (BCG), and a follow-up positron imaging tomography (PET-CT) revealed the presence of hypermetabolic nodule or a lymph node in the paraaortic region, inseparable from lower pole of the left kidney, measuring about 1.7 cm × 1 cm, suspicious for metastatic process. The multidisciplinary team agreed on proceeding for systematic chemotherapy, and to maintain the patient on regular cystoscopy follow-up, and commencing additional doses of intravesical BCG.

Discussion

The incidental finding of UTUC within a calyceal diverticulum during stone fragmentation is rare but clinically significant. 5 The shared embryological origin of the renal collecting system’s urothelium explains the histological similarity and the potential for carcinoma development in these areas. 9 Several risk factors contribute to UTUC, including chemical exposure, infections, pharmaceuticals, genetics, dietary habits, and smoking.2,3 Our patient, presenting at 48 years old, deviates from the typical epidemiological profile, highlighting the importance of considering malignancy across all age groups.1,10

The initial diagnostic workup did not reveal visible lesions, illustrating the challenges of diagnosing UTUC. However, positive urinary cytology prompted further investigation, revealing high-grade malignant cells, demonstrating the critical role of urinary cytology in UTUC diagnosis despite its limitations.1113 Radical nephroureterectomy is the standard treatment for UTUC, especially in cases with high-risk features such as multifocality and high-grade cytology. Our patient’s case, complicated by a horseshoe kidney and multifocal lesions at the stone impaction site, required an open right nephroureterectomy, highlighting the surgical complexity in such scenarios. 14

The occurrence of TCC in a calyceal diverticulum, as seen in this case, has been documented and is often associated with stone-containing diverticula due to chronic inflammation, infection, and irritation.57,1517 A review of these cases reveals no evidence that laser lithotripsy of the stone has led to tumor dissemination or implantation. Moreover, endoscopic techniques, including ureteroscopic and percutaneous approaches, have been utilized for managing UTUC through laser fulguration or biopsy, 18 and these have been associated with a higher risk of developing bladder recurrence.19,20 Significant predictors of bladder recurrence after radical nephroureterectomy include patient-specific factors like male gender and a history of bladder cancer, tumor-specific factors such as high-grade and ureteral location, and treatment-specific factors like the laparoscopic approach and positive surgical margins.2123 Diagnostic ureteroscopy has been linked to an increased risk of recurrence.19,20 A single dose of intravesical chemotherapy post-ureteroscopy for non-metastatic UTUC may reduce recurrence rates, based on low-level evidence. 21

High-risk factors for metastasis in upper tract TCC include high-grade cytology, local invasion, tumor size greater than 2 cm, high-grade biopsy, histological subtype, multifocality, and hydronephrosis. 24 Our patient’s multifocality and high-grade cytology indicated a high-risk disease. The presence of TCC in a calyceal diverticulum may contribute to early metastasis due to the lack of full-wall thickness in the diverticulum.

Our case challenges the diagnostic yield of routine approaches and prompts a reevaluation of biopsy strategies in cases of suspected UTUC, particularly in the absence of classic symptoms or prolonged symptomatic renal colic, with or without hematuria. This also raises questions about the utility of renal pelvis or calyx biopsy in cases with unremarkable stone characteristics, emphasizing the need for tailored diagnostic approaches based on individual patient presentations. 25

Conclusion

The presented case emphasizes the complexity of diagnosing UTUC, particularly in atypical presentations, emphasizing the importance of considering malignancy in stone patients with multiple risk factors and the necessity for tailored diagnostic approaches to optimize patient outcomes.

Acknowledgments

Special thanks to the Pathology Department at Najah National University Hospital for providing histopathology images used in this article, with gratitude extended to Dr. Hanood Abu Rass.

Footnotes

Author contributions: All authors had substantial contributions to conception and design, and all have agreed to submit to the current journal, and approving the final version to be published.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors received no financial support for the research, authorship, and/or publication of this article.

Ethical approval: Our institution, Najah National University Hospital, does not require ethical approval for reporting individual cases or case series.

Informed Consent: A written informed consent was obtained from the patient for the purpose of this article publication and all related images.

References

  • 1. Raman JD, Messer J, Sielatycki JA, et al. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int 2011; 107(7): 1059–1064. [DOI] [PubMed] [Google Scholar]
  • 2. Hafner C, Knuechel R, Stoehr R, et al. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 2002; 101(1): 1–6. [DOI] [PubMed] [Google Scholar]
  • 3. Jones TD, Wang M, Eble JN, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005; 11(18): 6512–6519. [DOI] [PubMed] [Google Scholar]
  • 4. Mohseni MG, Zand S, Aghamir SM. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Urol J 2004; 1(4): 250–252. [PubMed] [Google Scholar]
  • 5. Zuckerman JM, Passman C, Assimos DG. Transitional cell carcinoma within a calyceal diverticulum associated with stone disease. Rev Urol 2010; 12(1): 52–55. [PMC free article] [PubMed] [Google Scholar]
  • 6. Roberts CC, Collins JM, Lidner TK, et al. Transitional cell carcinoma obstructing a calyceal diverticulum: unusual presentation as a peripheral cystic mass. J Ultrasound Med 1999; 18(1): 19–21. [DOI] [PubMed] [Google Scholar]
  • 7. Nakano T, Kitagawa Y, Izumi K, et al. Invasive urothelial carcinoma within a calyceal diverticulum associated with renal stones: a case report. Oncol Lett 2015; 10(4): 2439–2441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Barkan GA, Wojcik EM, Nayar R, et al. The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology. J Am Soc Cytopathol 2016; 5(3): 177–188. [DOI] [PubMed] [Google Scholar]
  • 9. Melicow MM. Tumors of the urinary drainage tract: urothelial tumors. J Urol 1945; 54(2): 186–193. [Google Scholar]
  • 10. Rouprêt M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 2021; 79(1): 62–79. [DOI] [PubMed] [Google Scholar]
  • 11. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. Am J Roentgenol 2009; 192(6): 1488–1493. [DOI] [PubMed] [Google Scholar]
  • 12. Williams SK, Denton KJ, Minervini A, et al. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol 2008; 22(1): 71–76. [DOI] [PubMed] [Google Scholar]
  • 13. Zincke H, Aguilo JJ, Farrow GM, et al. Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J Urol 1976; 116(6): 781–783. [DOI] [PubMed] [Google Scholar]
  • 14. Lughezzani G, Sun M, Perrotte P, et al. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol 2010; 57(6): 956–962. [DOI] [PubMed] [Google Scholar]
  • 15. An L, Xiong L, Xu Q, et al. Incidental diagnosis of renal pelvic tumor in patients who underwent percutaneous nephrolithotomy: a report of 6 cases and review of the literature. Urology 2023; 171: 64–70. [DOI] [PubMed] [Google Scholar]
  • 16. Mitome T, Tabei T, Tsuura Y, et al. Squamous cell carcinoma in a calyceal diverticulum detected by percutaneous nephroscopic biopsy. Case Rep Oncol Med 2018; 2018: 3508537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Chow WH, Lindblad P, Gridley G, et al. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 1997; 89(19): 1453–1457. [DOI] [PubMed] [Google Scholar]
  • 18. Cinman NM, Andonian S, Smith AD. Lasers in percutaneous renal procedures. World J Urol 2010; 28(2): 135–142. [DOI] [PubMed] [Google Scholar]
  • 19. Marchioni M, Primiceri G, Cindolo L, et al. Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int 2017; 120(3): 313–319. [DOI] [PubMed] [Google Scholar]
  • 20. Guo RQ, Hong P, Xiong GY, et al. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 2018; 121(2): 184–193. [DOI] [PubMed] [Google Scholar]
  • 21. Seisen T, Granger B, Colin P, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 2015; 67(6): 1122–1133. [DOI] [PubMed] [Google Scholar]
  • 22. Zhang X, Bu R, Liu Z, et al. Development and validation of a model for predicting intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: a retrospective study in one center with long-term follow-up. Pathol Oncol Res 2020; 26(3): 1741–1748. [DOI] [PubMed] [Google Scholar]
  • 23. Sheu ZL, Huang CP, Chang CH, et al. Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy. Sci Rep 2021; 11(1): 19059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Rouprêt M, Seisen T, Birtle AJ, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol 2023; 84(1): 49–64. [DOI] [PubMed] [Google Scholar]
  • 25. Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 2000; 163(1): 52–55. [DOI] [PubMed] [Google Scholar]

Articles from SAGE Open Medical Case Reports are provided here courtesy of SAGE Publications

RESOURCES